to answer some of my own questions.
CANVAS is a double-blind trial, meaning patients, investigators, doctors administering the treatment are blinded. This means that someone independent of all this needs to be involved in managing the trial
this is referred to as a data safety monitoring committee
you can read up about one here
http://en.wikipedia.org/wiki/Data_monitoring_committee
- Forums
- ASX - By Stock
- IMM
- igcs abstract
igcs abstract, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 805 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 169 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 805 | 0.425 |
3 | 6470 | 0.365 |
2 | 1736 | 0.355 |
2 | 25205 | 0.350 |
3 | 8039 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 169 | 1 |
0.355 | 11000 | 1 |
0.360 | 109296 | 4 |
0.365 | 47800 | 3 |
0.370 | 110306 | 3 |
Last trade - 09.58am 20/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
Day chart unavailable